Alleging that Abbvie Inc. made billions of dollars through violations of the Anti-Kickback Statute, or AKS, that boosted sales of Humira, an injectable drug used to treat autoimmune diseases, Lozaro Suarez filed a qui tam complaint against the pharmaceutical company in Chicago under the False Claims Act, or FCA.Suarez alleged the following facts: When sales of Humira started to slow down, Abbvie implemented the Ambassador program. The Ambassadors were nurses that Abbvie sent to doctors and patients. In addition to training …